ADC biomanufacturing pipeline intelligence

1000+

Active ADC programs

7 days

Surveillance sync cycle

100%

Human analyst verified

400+

China-origin signals

Pipeline surveillance and analyst verification

Structured clinical lead rows

Every record captures Company, Asset, Target antigen, Payload-linker details, clinical Phase, and Last Updated timestamps formatted specifically for BD outreach workflows.

Three-stage signal filtration model

Automated monitoring scans global trial registries, patent publications, and Chinese regulatory filings before biopharma domain analysts verify biomanufacturing procurement readiness.

Phase 1 transition report

Fresh validation guarantee

Every custom report purchase is freshly re-validated by senior biopharma analysts within 24 hours of order placement to ensure zero stale registry data.

10 Phase 1 ADC transition signals

Download this month's sample dispatch detailing ten antibody-drug conjugate programs advancing into clinical Phase 1 with verified payload-linker chemistry and sponsor contact points.

Choose between instant individual sample reports, single-org team licenses, or continuous weekly intelligence dispatches tailored for biomanufacturing BD teams.

Single User $995

Team License $1,800

Founding Sub $800/mo

Full Report License

Commercial Team Access

Continuous Pipeline Feed

Complete intelligence feed covering ~270 active ADC clinical programs in a single structured report licensed to one named business development executive with 24-hour validation.

Organization-wide intelligence distribution covering up to 10 BD team members across commercial development, biomanufacturing strategy, and contract manufacturing lead generation.

Full continuous database access with weekly pipeline update dispatches, China-origin Phase 1 transition alerts, and direct analyst consultation slots.